252 related articles for article (PubMed ID: 16101546)
1. Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.
Milner JM; Cawston TE
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):363-75. PubMed ID: 16101546
[TBL] [Abstract][Full Text] [Related]
2. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.
Elliott S; Cawston T
Drugs Aging; 2001; 18(2):87-99. PubMed ID: 11346130
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases: role in arthritis.
Burrage PS; Mix KS; Brinckerhoff CE
Front Biosci; 2006 Jan; 11():529-43. PubMed ID: 16146751
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritis.
Mix KS; Sporn MB; Brinckerhoff CE; Eyre D; Schurman DJ
Clin Orthop Relat Res; 2004 Oct; (427 Suppl):S129-37. PubMed ID: 15480055
[TBL] [Abstract][Full Text] [Related]
5. Joint diseases and matrix metalloproteinases: a role for MMP-13.
Takaishi H; Kimura T; Dalal S; Okada Y; D'Armiento J
Curr Pharm Biotechnol; 2008 Feb; 9(1):47-54. PubMed ID: 18289056
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
[TBL] [Abstract][Full Text] [Related]
7. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
8. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis.
Smith GN
Front Biosci; 2006 Sep; 11():3081-95. PubMed ID: 16720377
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
[TBL] [Abstract][Full Text] [Related]
10. [Cartilage degradation in rheumatoid arthritis].
Ishiguro N
Clin Calcium; 2009 Mar; 19(3):347-54. PubMed ID: 19252244
[TBL] [Abstract][Full Text] [Related]
11. Matrix-degrading metalloproteinases and their roles in joint destruction.
Okada Y
Mod Rheumatol; 2000 Sep; 10(3):121-8. PubMed ID: 24383588
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitors in rheumatic diseases.
Close DR
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii62-7. PubMed ID: 11890658
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
14. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
Kobayashi K; Arimura Y; Goto A; Okahara S; Endo T; Shinomura Y; Imai K
J Pathol; 2006 Jul; 209(3):376-83. PubMed ID: 16552705
[TBL] [Abstract][Full Text] [Related]
16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
17. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
Skiles JW; Gonnella NC; Jeng AY
Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases. Novel targets for directed cancer therapy.
Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases in inflammatory pathologies of the horse.
Clutterbuck AL; Harris P; Allaway D; Mobasheri A
Vet J; 2010 Jan; 183(1):27-38. PubMed ID: 19022687
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases.
Cawston T
Mol Med Today; 1998 Mar; 4(3):130-7. PubMed ID: 9575496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
